fig1
![The advancement of immunotherapy in hepatocellular carcinoma](https://image.oaes.cc/bf465a79-f62f-4cd8-bf70-40d6b6f956dd/3449.fig.1.jpg)
Figure 1. An overview of the different immunotherapy approaches for the treatment of hepatocellular carcinoma, which includes immune checkpoint inhibitor antibodies, adoptive cell transfer, dendritic cell-based vaccines and oncolytic therapy. CIK: cytokine-induced killer; NK: natural killer; TCR: T cell receptor; CAR: chimeric antigen receptor